Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma
Authors:
- Ho Won KangHKHo Won Kang
- Hongyong ParkHPHongyong Park
- Sung Pil SeoSSSung Pil Seo
- Young Joon ByunYBYoung Joon Byun
- Xuan-Mei PiaoXPXuan-Mei Piao
- Sung Min KimSKSung Min Kim
- Won Tae KimWKWon Tae Kim
- Seok-Joong YunSYSeok-Joong Yun
- Wooyeong JangWJWooyeong Jang
- Ho Sun ShonHSHo Sun Shon
- Keun Ho RyuKeun Ho Ryu
- Sang-Cheol LeeSLSang-Cheol Lee
Open Access
- 1 January 2019
- journal article
- research article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 34 (19) , e144
Abstract
Kang HW, et al. J Korean Med Sci. 2019 May;34(19):e144. https://doi.org/10.3346/jkms.2019.34.e144Keywords
Funding Information
- National Research Foundation of Korea (2015R1D1A1A01057786, 2018R1D1A1B07043906)
This publication has 29 references indexed in Scilit:
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2012
- Renal cancer biomarkers: the promise of personalized careBMC Medicine, 2012
- State of the Science: An Update on Renal Cell CarcinomaMolecular Cancer Research, 2012
- Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomasCarcinogenesis, 2012
- Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinomaEpigenetics, 2012
- Genome-Wide Association Study of Pancreatic Cancer in Japanese PopulationPLOS ONE, 2010
- CpG methylation profiling in VHL related and VHL unrelated renal cell carcinomaMolecular Cancer, 2009
- DNA methylation and gene silencing in cancerNature Clinical Practice Oncology, 2005
- Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinomaCancer, 2004
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003